Proposed Standardized Neurological Endpoints for Cardiovascular Clinical Trials: An Academic Research Consortium Initiative.

Abstract

Surgical and catheter-based cardiovascular procedures and adjunctive pharmacology have an inherent risk of neurological complications. The current diversity of neurological endpoint definitions and ascertainment methods in clinical trials has led to uncertainties in the neurological risk attributable to cardiovascular procedures and inconsistent evaluation… (More)
DOI: 10.1016/j.jacc.2016.11.045

Topics

8 Figures and Tables

Cite this paper

@article{Lansky2017ProposedSN, title={Proposed Standardized Neurological Endpoints for Cardiovascular Clinical Trials: An Academic Research Consortium Initiative.}, author={Alexandra J Lansky and Steven R. Mess{\'e} and Adam M. Brickman and Michael Dwyer and H. Bart van der Worp and Ronald M. Lazar and Cody G. Pietras and Kevin J. Abrams and Eugene Mcfadden and Nils Holger Petersen and Jeffrey N. Browndyke and Bernard D. Prendergast and Vivian G. Ng and Donald E. Cutlip and Samir R Kapadia and Mitchell W. Krucoff and Axel Linke and Claudia Scala Moy and Joachim J Schofer and Gerrit-Anne van Es and Renu Virmani and Jeffrey J. Popma and Michael K Parides and Susheel K. Kodali and Michel Bilello and Robert Zivadinov and J. G. Akar and Karen L. Furie and Daryl R. Gress and Szilard Voros and Jeffrey W. Moses and David Greer and John Forrest and David Holmes and Arie Pieter Kappetein and M. Catherine Mack and Andreas Baumbach}, journal={European heart journal}, year={2017} }